Your shopping cart is currently empty

NK224 is a peptide-based radiotracer targeting human PD-L1, designed for dual radionuclide labeling compatibility using a NOTA chelator with both [68Ga and 18F]. It exhibits high binding affinity to PD-L1, with an IC50 value of 2.45 nM. NK224 enables visualization of tumor heterogeneity in patients and dynamic monitoring of PD-L1 target occupancy during immunotherapy. It is applicable to non-small cell lung cancer (NSCLC) research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NK224 is a peptide-based radiotracer targeting human PD-L1, designed for dual radionuclide labeling compatibility using a NOTA chelator with both [68Ga and 18F]. It exhibits high binding affinity to PD-L1, with an IC50 value of 2.45 nM. NK224 enables visualization of tumor heterogeneity in patients and dynamic monitoring of PD-L1 target occupancy during immunotherapy. It is applicable to non-small cell lung cancer (NSCLC) research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.